{"altmetric_id":460756,"counts":{"readers":{"mendeley":51,"citeulike":2,"connotea":1},"facebook":{"unique_users_count":1,"unique_users":["153821831341506"],"posts_count":1},"blogs":{"unique_users_count":1,"unique_users":[2137],"posts_count":1},"policy":{"unique_users_count":2,"unique_users":["nap","nice"],"posts_count":2},"total":{"posts_count":10},"twitter":{"unique_users_count":4,"unique_users":["fukurock1980","maxjhowden","Magil2006","MrPug94"],"posts_count":6}},"selected_quotes":["@LungCancerFaces I'm not a Doc. these letters to editor in '05","@JackWestMD thanks for ur reply. Should letters to Editor","@MariaJosepCarre Ay que me picas! \u00bfPor este? No pienso que no. Me cuesta mucho lo d pausabilidad biol\u00f3gica -","@JackWestMD The letters to the editor in BR.21"],"citation":{"abstract":"Some features of breast cancer in women with a BRCA1 mutation suggest that hereditary breast cancer has a poor outcome. We conducted a national population-based study of Israeli women to determine the influence, if any, of a BRCA1 or a BRCA2 mutation on the prognosis in breast cancer.","abstract_source":"pubmed","altmetric_jid":"4f6fa50e3cf058f6100031c4","authors":["Frances A. Shepherd","Jos\u00e9 Rodrigues Pereira","Tudor Ciuleanu","Eng Huat Tan","Vera Hirsh","Sumitra Thongprasert","Daniel Campos","Savitree Maoleekoonpiroj","Michael Smylie","Renato Martins","Maximiliano van Kooten","Mircea Dediu","Brian Findlay","Dongsheng Tu","Dianne Johnston","Andrea Bezjak","Gary Clark","Pedro Santab\u00e1rbara","Lesley Seymour","Shepherd, Frances A.","Rodrigues Pereira, Jos\u00e9","Ciuleanu, Tudor","Tan, Eng Huat","Hirsh, Vera","Thongprasert, Sumitra","Campos, Daniel","Maoleekoonpiroj, Savitree","Smylie, Michael","Martins, Renato","van Kooten, Maximiliano","Dediu, Mircea","Findlay, Brian","Tu, Dongsheng","Johnston, Dianne","Bezjak, Andrea","Clark, Gary","Santab\u00e1rbara, Pedro","Seymour, Lesley"],"doi":"10.1056\/nejmoa050753","endpage":"132","first_seen_on":"2011-11-18T13:58:36+00:00","handles":[],"isbns":[],"issns":["0028-4793","1533-4406"],"issue":"2","journal":"New England Journal of Medicine","last_mentioned_on":1486354018,"links":["http:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa050753","http:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa050753#t=articleMethods","http:\/\/dx.doi.org\/10.1056\/NEJMoa050753","http:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa050753#letters"],"pmid":"17625123","pubdate":"2005-07-14T00:00:00+00:00","publisher":"Mass Med Soc","publisher_subjects":[{"name":"Medical And Health Sciences","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"startpage":"123","subjects":["medicine"],"title":"Erlotinib in Previously Treated Non\u2013Small-Cell Lung Cancer","type":"article","uri":"http:\/\/www.nejm.org\/doi\/abs\/10.1056\/NEJMoa050753","volume":"353","mendeley_url":"http:\/\/www.mendeley.com\/research\/erlotinib-previously-treated-nonsmallcell-lung-cancer-25"},"altmetric_score":{"score":15.766,"score_history":{"1y":2,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":15.766},"context_for_score":{"all":{"total_number_of_other_articles":8170298,"mean":6.9145785001388,"rank":528908,"this_scored_higher_than_pct":93,"this_scored_higher_than":7641462,"rank_type":"exact","sample_size":8170298,"percentile":93},"similar_age_3m":{"total_number_of_other_articles":245420,"mean":5.1165477571014,"rank":14145,"this_scored_higher_than_pct":94,"this_scored_higher_than":231274,"rank_type":"exact","sample_size":245420,"percentile":94},"this_journal":{"total_number_of_other_articles":20064,"mean":47.819481034741,"rank":6697,"this_scored_higher_than_pct":66,"this_scored_higher_than":13367,"rank_type":"exact","sample_size":20064,"percentile":66},"similar_age_this_journal_3m":{"total_number_of_other_articles":338,"mean":37.697008902077,"rank":175,"this_scored_higher_than_pct":48,"this_scored_higher_than":163,"rank_type":"exact","sample_size":338,"percentile":48}}},"demographics":{"poster_types":{"member_of_the_public":2,"researcher":1,"practitioner":1},"users":{"twitter":{"cohorts":{"Members of the public":2,"Scientists":1,"Practitioners (doctors, other healthcare professionals)":1}},"mendeley":{"by_status":{"Professor > Associate Professor":3,"Researcher":4,"Student  > Doctoral Student":2,"Student  > Ph. D. Student":12,"Student  > Postgraduate":7,"Other":6,"Student  > Master":9,"Student  > Bachelor":7,"Lecturer":1},"by_discipline":{"Engineering":1,"Medicine and Dentistry":23,"Chemistry":3,"Social Sciences":1,"Agricultural and Biological Sciences":9,"Computer Science":1,"Nursing and Health Professions":1,"Business, Management and Accounting":1,"Biochemistry, Genetics and Molecular Biology":6,"Unspecified":1,"Pharmacology, Toxicology and Pharmaceutical Science":4}}},"geo":{"twitter":{"SE":1,"FR":1,"US":1},"mendeley":{"GB":1,"ES":1}}},"posts":{"facebook":[{"title":"\u660e\u65e5\u306f","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=198619410195081&id=153821831341506","license":"public","citation_ids":[460756],"posted_on":"2011-07-30T01:44:55+00:00","summary":"\u6691\u3044\u3068\u3044\u3063\u3066\u3082\u590f\u3089\u3057\u3044\u30fb\u30fb\u3068\u3044\u3046\u3088\u308a\u3001\u84b8\u3057\u6691\u3044\u4eca\u65e5\u3053\u306e\u9803\u3067\u3059\u304c\u3001\u660e\u65e5\u306fEBM-Osaka\u52c9\u5f37\u4f1a\u3092\u958b\u50ac\u3044\u305f\u3057\u307e\u3059\u3002\n\u4eca\u56de\u306f\u5c11\u3057\u53e4\u3044\u3082\u306e\u3067\u3059\u304c\u3001\u201dErlotinib in Previously Treated Non\u2013Small-Cell Lung Cancer\u201d\nhttp:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa050753\n\u30bf\u30eb\u30bb\u30d0\u306e\u8ad6\u6587\u3067\u3059\u3002\n\u00a0\n\u30bf\u30eb\u30bb\u30d0\u3092\u4f7f\u7528\u3059\u308b\u60a3\u8005\u3055\u3093\u304b\u3089\u306e\u533b\u7642\u76f8\u8ac7\u3068\u3044\u3046\u306e\u306f\u3001\u5b9f\u969b\u306e\u3068\u3053\u308d\u6709\u7121\u3092\u8a00\u308f\u3055\u306a\u3044\u72b6\u6cc1\u306e\u3053\u3068\u304c\u307b\u3068\u3093\u3069\u3067\u3059\u3002\u3059\u3067\u306b\u4ed6\u6cbb\u7642\u3092\u884c\u3063","author":{"name":"EBM-Osaka","url":"https:\/\/www.facebook.com\/153821831341506","facebook_wall_name":"EBM-Osaka","image":"https:\/\/graph.facebook.com\/153821831341506\/picture","id_on_source":"153821831341506"}}],"blogs":[{"title":"The Epigenetic Two-Punch Cancer Treatment from Johns Hopkins","url":"http:\/\/www.epiexperts.com\/blog\/the-epigenetic-two-punch-cancer-treatment-from-johns-hopkins\/","citation_ids":[460756,460757,460758],"posted_on":"2011-11-18T09:16:00+00:00","summary":"The big news in epigenetics this week is a two-drug epigenetic combo that shows results as good as the best FDA-approved chemotherapy in fighting non-small cell lung cancer, which accounts for about 80 percent such cancers. But missing from a lot of the ma","author":{"name":"Epigenetics Experts Blog","url":"http:\/\/www.epiexperts.com\/blog","description":"Engaging Ideas"}}],"twitter":[{"url":"http:\/\/twitter.com\/fukurock1980\/statuses\/226077250271973376","license":"public","citation_ids":[460756],"posted_on":"2012-07-19T22:13:11+00:00","author":{"name":"twins","image":"http:\/\/pbs.twimg.com\/profile_images\/477876570846023681\/9CCVCTsp_normal.jpeg","description":"Aphex twin \u304c\u597d\u304d\u3002\n\u5a18\u3082\u53cc\u5b50\u3002\n\u535a\u58eb\u8ab2\u7a0b\u3068\u80b2\u5150\u3068\u4ed5\u4e8b\u3002","id_on_source":"fukurock1980","tweeter_id":"389435756","geo":{"lt":"63.3421028","ln":"13.473","country":"SE"},"followers":68},"tweet_id":"226077250271973376"},{"url":"http:\/\/twitter.com\/maxjhowden\/statuses\/773615339468906500","license":"gnip","citation_ids":[460756],"posted_on":"2016-09-07T20:14:04+00:00","author":{"name":"Joseph Max Howden","url":"https:\/\/medium.com\/@maxjhowden","image":"https:\/\/pbs.twimg.com\/profile_images\/911383447389818881\/Rs7AlmYA_normal.jpg","description":"Physics and Aerospace Engineering Major, UWEC Student Senator, Mens Soccer Recruit","id_on_source":"maxjhowden","tweeter_id":"3407376472","geo":{"lt":49.73326,"ln":4.82939,"country":"FR"},"followers":628},"tweet_id":"773615339468906500"},{"url":"http:\/\/twitter.com\/Magil2006\/statuses\/788496724839006208","license":"gnip","citation_ids":[460756],"posted_on":"2016-10-18T21:47:23+00:00","author":{"name":"Mari\u00e1ngel Gil","image":"https:\/\/pbs.twimg.com\/profile_images\/760498520252149760\/Obcoy5Is_normal.jpg","description":"Los que me conoc\u00e9is ya sab\u00e9is, los que ya sab\u00e9is no me conoc\u00e9is. Botica del hospital y otras inquietudes.","id_on_source":"Magil2006","tweeter_id":"921568016","geo":{"lt":null,"ln":null},"followers":644},"tweet_id":"788496724839006208"},{"url":"http:\/\/twitter.com\/MrPug94\/statuses\/828320975397662720","license":"gnip","citation_ids":[460756],"posted_on":"2017-02-05T19:14:44+00:00","author":{"name":"Brian Shields","url":"http:\/\/www.latimes.com\/business\/la-fi-genentech-tarceva-settlement-20160607-snap-story.html","image":"https:\/\/pbs.twimg.com\/profile_images\/753058072768098304\/6Fqger_P_normal.jpg","description":"Former Army Aviator, USMA grad, Cancer Advocate, Pharma Whistleblower","id_on_source":"MrPug94","tweeter_id":"164254921","geo":{"lt":37.25022,"ln":-119.75126,"country":"US"},"followers":6117},"tweet_id":"828320975397662720"},{"url":"http:\/\/twitter.com\/MrPug94\/statuses\/828322839778308096","license":"gnip","citation_ids":[460756],"posted_on":"2017-02-05T19:22:09+00:00","author":{"name":"Brian Shields","url":"http:\/\/www.latimes.com\/business\/la-fi-genentech-tarceva-settlement-20160607-snap-story.html","image":"https:\/\/pbs.twimg.com\/profile_images\/753058072768098304\/6Fqger_P_normal.jpg","description":"Former Army Aviator, USMA grad, Cancer Advocate, Pharma Whistleblower","id_on_source":"MrPug94","tweeter_id":"164254921","geo":{"lt":37.25022,"ln":-119.75126,"country":"US"},"followers":6117},"tweet_id":"828322839778308096"},{"url":"http:\/\/twitter.com\/MrPug94\/statuses\/828454917694119936","license":"gnip","citation_ids":[460756],"posted_on":"2017-02-06T04:06:58+00:00","author":{"name":"Brian Shields","url":"http:\/\/www.latimes.com\/business\/la-fi-genentech-tarceva-settlement-20160607-snap-story.html","image":"https:\/\/pbs.twimg.com\/profile_images\/753058072768098304\/6Fqger_P_normal.jpg","description":"Former Army Aviator, USMA grad, Cancer Advocate, Pharma Whistleblower","id_on_source":"MrPug94","tweeter_id":"164254921","geo":{"lt":37.25022,"ln":-119.75126,"country":"US"},"followers":6117},"tweet_id":"828454917694119936"}],"policy":[{"title":"Assessing and Improving Value in Cancer Care: Workshop Summary","url":"https:\/\/www.nap.edu\/download\/12644","license":"public","citation_ids":[1377379,221120,1537071,3232703,5755238,173368,14491246,1428862,1912561,2848941,1790144,1336221,2322769,14491251,460756,14491253,14489114,568248,14491258,14491259,1033353,1321507,14491261,14491265,8444589,14491268,14491270,3725279,14491272,2432401,14491275,4027417,14491278,210833,3208110,14491281,1486901,1057966,512289,210485,2139854,541133,1429082,14491292,14491292,14491292],"posted_on":"2009-01-01T00:00:00+00:00","source":{"name":"National Academies Press","description":"The US National Academies Press (NAP) was created by the National Academy of Sciences to publish the reports of the National Academies of Sciences, Engineering and Medicine, operating under a charter granted by the Congress of the United States. The NAP publishes on a wide range of topics in science, engineering, and medicine, providing authoritative information on important matters in science and health policy.","geo":{"country":"US"}},"page_url":"https:\/\/www.nap.edu\/catalog\/12644\/assessing-and-improving-value-in-cancer-care-workshop-summary","collections":[],"author":{"image":"https:\/\/s3.amazonaws.com\/cache.altmetric.com\/policy\/thumbnails\/thumbnail-461e66016ba5cda73c586f0be3a65f97cd3bf1bed129ac72069cbaf1a1505daf.jpg"}},{"title":"Ceritinib for previously treated anaplastic lymphoma kinase positive non-small-cell lung cancer: Committee papers","url":"https:\/\/www.nice.org.uk\/guidance\/TA395\/documents\/committee-papers","license":"public","citation_ids":[460756,2220983,2086526],"posted_on":"2016-01-15T00:00:00+00:00","source":{"name":"National Institute for Health and Care Excellence","description":"The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.","geo":{"country":"GB"}},"page_url":"https:\/\/www.nice.org.uk\/guidance\/ta395\/evidence","collections":[],"author":{"image":"https:\/\/s3.amazonaws.com\/cache.altmetric.com\/policy\/thumbnails\/thumbnail-17571df4a5bc6726b688ff03e653cdb14635657fa9acb87d9738e19a96e4e1a3.jpg"}}]}}